The sudden wave of pregnancies among those on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has surprised patients and doctors alike
Dawkins and Pratley note that while studies show people with obesity and type 2 diabetes experience significant weight loss on a GLP-1 agonist or dual agonist, people with type 2 diabetes experience slightly less weight loss compared with those with overweight and obesity without type 2 diabetes.1-3 Counseling Tips for RDs Despite the success of these classes of weight management medications, patients can receive anywhere from a little to a lot of information on how to optimize their use since a wide variety of clinicians, from primary care providers to obesity medicine experts, prescribe them
Renal function must be considered, as some GLP-1 agents require dose adjustment or have limitations in advanced chronic kidney disease
This is one of the reasons its key to maintain a healthy diet while taking a GLP-1
Some experts have called GLP-1s the most important drug class breakthrough in medical history , comparing their impact to the discovery of insulin
My weight loss was inconsistent, my appetite suppression varied, and I constantly questioned whether the medication, my dosing, or my injection technique was responsible
